https://www.selleckchem.com/products/OSI-906.html
05); the total incidence of adverse reactions in the study group and the control group was 2.94% and 23.53% respectively, (P0.05); the two groups were followed up for 24 months, and the disease control rate (DCR) of the control group was 58.82%, significantly lower than 85.29% in the study group; the PFS time of the control group was (15.68±4.23) lower than that of the study group (18.12±5.42) (P0.05). Interventional ultrasound injection of cisplatin in the treatment of HCC has a definite effect. It can effectively relieve liver